Antipsychotics and Metabolic Syndrome

Status

Suspended

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00636753

Enrollment

Registered

2008-03-14

Start date

2008-09-30

Completion date

Unknown

Last updated

2010-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Keywords

Metabolic and endocrine changes in schizophrenic patients by antipsychotics treatment.

Brief summary

The purpose of the study is to determine whether antipsychotic treatment is influence psychiatric patients due to endocrine and metabolic status and quality of life.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

* Gender male * Age 18-45 * Debut drug-naive schizophrenics, * Caucasians * Consent given to take part in the project

Exclusion criteria

* Compliance-problems * Major lung-/kidney/hart/lever disorders * Abuse of alcohol/drugs * Diabetes 1 and 2 * Antihypertensive * Anticholesterol-reducing medication * Patients under duress

Countries

Denmark

Outcome results